Related Experiment Videos
The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality
Magdalena Sobieraj-Teague1, Alexander S Gallus, John W Eikelboom
1Department of Haematology, Flinders Medical Centre, Adelaide, Australia. benek_i_magda@hotmail.com
Insights
Bleeding is a common complication in acute coronary syndrome (ACS) patients, increasing morbidity and mortality. Strategies to reduce bleeding are crucial for improving patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Bleeding is a frequent complication of antithrombotic therapy in acute coronary syndrome (ACS).
- Major bleeding affects approximately 5% of ACS patients, with risk factors including age, sex, renal impairment, and invasive procedures.
Purpose of the Study:
- To review the association between bleeding and adverse outcomes in ACS patients.
- To explore the mechanisms linking bleeding to adverse events.
- To identify strategies for reducing bleeding complications in ACS.
Main Methods:
- Literature review of studies on bleeding complications in acute coronary syndrome.
- Analysis of risk factors, outcomes, and management strategies for bleeding in ACS.
Main Results:
- Major bleeding in ACS is independently associated with increased early and long-term morbidity and mortality.
- Potential mechanisms include anemia, hypovolemia, treatment modification, and transfusion effects.
- Bleeding complications can potentially be reduced with newer antithrombotic agents and optimized dosing.
Conclusions:
- Further research is needed to evaluate the impact of bleeding reduction strategies on overall morbidity and mortality in ACS.
- Standardized definitions for bleeding severity are required.
- Future trials should report all clinically relevant bleeding outcomes and transfusions, investigate bleeding risk reduction, understand post-bleeding adverse outcomes, and establish best practices for management.
Purpose Of Review:
This review examines the association between bleeding and adverse outcomes in patients with acute coronary syndrome and explores mechanisms behind this association and strategies for reducing bleeding complications in acute coronary syndrome.
Recent Findings:
Bleeding is a common complication of antithrombotic treatment in acute coronary syndrome, and major bleeding occurs in around 5% of patients. Important risk factors for major bleeding include increasing age, female sex, renal impairment, and invasive procedures. Recent studies suggest that major bleeding in patients with acute coronary syndrome is independently associated with an increase of early and long-term morbidity and mortality. This may be due to the direct effects of anaemia and hypovolaemia, the treatment modification or withdrawal, or the adverse effects of transfusion. Bleeding complications may be reduced by use of new antithrombotic agents and by improved attention to dosing with current agents.
Summary:
Future studies should examine the effects on overall morbidity and mortality of strategies designed to reduce bleeding complications in patients with acute coronary syndrome. There is a need to apply uniform definitions of bleeding severity. Future trials should report all clinically relevant bleeding outcomes and transfusions. Studies are needed to investigate methods to reduce the risk of bleeding, better understand mechanisms of adverse outcome after bleeding, and establish best practice for the management of bleeding including appropriate use of transfusion in patients with acute coronary syndrome.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies